Johnson & Johnson expected to keep battling talc claims despite losses: expert

Fierce Pharma -------- Having lost four talc cases worth more than $300 million, Johnson & Johnson is engaged in a tough legal battle against thousands of liability claims alleging routine use caused ovarian cancer. Despite the setbacks to date, one expert thinks the drugmaker will continue to take a tough stand against the cases rather than settle. The drug giant is currently in the process of appealing the cases it's lost, and is prepping for more trials this year as it holds fast to its defensive strategy.“If Johnson & Johnson thought the plaintiffs had a silver bullet, their strategy might be different,” attorney Mark Raffman of Goodwin told FiercePharma. Raffman said that plaintiffs are trying to prove an “industry conspiracy” to hide the risks of routine talc use, but that it might be a stretch.“From what I’ve read, they don’t have evidence to back that up and aren’t going to find it.” To learn more click on the picture below to read the article.